Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI

NCT ID: NCT01329601

Last Updated: 2011-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to detect the effect of a structured cognitive rehabilitation program, teh stage specific intervention STACog, on cognitive performance and functional activation in fMRI in a group of patients with mild cognitive impairment and dementia due to Alzheimer's disease compared to a waiting group control sample. Baseline performance in cognitive tests and fMRI will further be assessed compared to healthy control subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subject of the proposed project is to offer based on existing theoretical principles and methods stage-related, reproducible, relevant to everyday life group training in German for people with aMCI and slightly severe AD and compared with a - in terms of goal variables - to be less effective prestigious intervention . It is believed that the "active treatment" - in the intervention group, the overall level of functioning can longer be maintained and that positive transfer effects on non-cognitive level - to achieve and cognitive level - here at nationals. In addition, information is expected that the conversion rate of people with dementia and aMCI cut to a further loss of independence in humans can be delayed slightly with severe AD. The project aims to provide data to estimate the effect sizes of intervention can be determined on the basis of group size and duration of ongoing investigations.

Involving functional imaging measures, the intervention study, an adequate platform for the detection of intervention effects on neurobiological basis using fMRI dar. Here, the cerebral blood flow in specific activation as a measure of neuronal and synaptic activity and integrity both in cross-section of a subsample of healthy elderly people studied determined and changes in cerebral activity patterns in people with severe AD, aMCI or slightly in comparison pre-/post interventions. There are detectable much earlier in the pathogenesis of functional changes as structural, using fMRI, the study is to make a significant contribution to prove whether a modular cognitive intervention altered neural and synaptic activity and whether this change is accompanied by an improvement in cognitive performance.

A complete and proven effectiveness of cognitive group training could make a significant contribution that people with MCI and severe AD easily submit their own initiative mental condition, and add itself to sustain the intellectual, emotional and social potential. As a long-term perspective, the results for the optimization of cognitive intervention programs and continue to implement the organizations of the open and contribute stationary the elderly and specialized medical facilities and other medical facilities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia of the Alzheimer Type

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cognitive Intervention

StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI

Group Type EXPERIMENTAL

StaCog, stage specific cognitive Intervention

Intervention Type BEHAVIORAL

StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI

Booklet-based training

Home based training of episodic memory using paper-pencil exercizes

Group Type ACTIVE_COMPARATOR

booklet based training

Intervention Type BEHAVIORAL

Home based training of episodic memory using paper-pencil exercizes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

StaCog, stage specific cognitive Intervention

StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI

Intervention Type BEHAVIORAL

booklet based training

Home based training of episodic memory using paper-pencil exercizes

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cognitive rehabilitation Active behavioural control

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis of Mild Cognitive Impairment, Amnestic type (single domain) according to Petersen criteria or a low grade AD according to ICD-10/NINCDS-ADRDA

Exclusion Criteria

* Major depression
* severe visual and acoustic impairment
* severe physical impairments
* known malignancy
* laboratory elevated inflammatory markers (ESR, CRP, leukocytes)
* stroke
* brain trauma
* epilepsy
* previous participation in a memory training
* patients receiving drug treatment (antidepressants, neuroleptics, anti-dementia, other brain performance enhancing drugs) at least three months prior to study initiation for the duration of the project are at a stable dosage
Minimum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

DZNE, German Center for Neurodegenerative Disorders, Germany

UNKNOWN

Sponsor Role collaborator

University of Rostock

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Psychiatry, University Rostock

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefan J. Teipel, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Rostock

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Psychiatry, University of Rostock

Rostock, Mecklenburg-Vorpommern, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stefan J. Teipel, Prof. Dr.

Role: CONTACT

0049-381-494 ext. 9471

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stefan J. Teipel, Prof. Dr.

Role: primary

0049-381-494 ext. 9471

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Int_HRO_1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.